US Patent Issued to Iovance Biotherapeutics on May 19 for "Expansion of tumor infiltrating lymphocytes with potassium channel agonists and therapeutic uses thereof" (Florida, Pennsylvania Inventors)

ALEXANDRIA, Va., May 19 -- United States Patent no. 12,629,356, issued on May 19, was assigned to Iovance Biotherapeutics Inc. (San Carlos, Calif.).

"Expansion of tumor infiltrating lymphocytes with potassium channel agonists and therapeutic uses thereof" was invented by Krit Ritthipichai (Tampa, Fla.) and Michael T. Lotze (Pittsburgh).

According to the abstract* released by the U.S. Patent & Trademark Office: "Methods of expanding tumor infiltrating lymphocytes (TILs) using a potassium channel agonist, such as a KCa3.1 (IK channel) agonist, and uses of such expanded TILs in the treatment of diseases such as cancer are disclosed herein."

The patent was filed on June 10, 2022, under Application No. 17/838,127.

*For further information, i...